Huaxi Biotech: Huaxi Biotech\'s 2024 Third Quarter Report

SZSIOct 30 12:00 ET · Announcements

Huaxi Biotech 2024 Third Quarter Report

SZSIOct 30 12:00 ET · Announcements

Bloomage Biotechnology Corporation Limited (688363.SH): The net income for the first three quarters was 0.362 billion yuan, a year-on-year decrease of 29.6%.

Glory Power reported on October 30 that Bloomage Biotechnology Corporation Limited (688363.SH) achieved revenue of 3.875 billion yuan in the first three quarters, a year-on-year decrease of 8.2%; net income attributable to the parent company was 0.362 billion yuan, a year-on-year decrease of 29.6%; non-net profit attributable to the parent company was 0.327 billion yuan, a year-on-year decrease of 24.6%.

Gelonghui FinanceOct 30 09:56 ET

Express News | Bloomage Biotech Q3 Net Profit Down 77.4% Y/Y

ReutersOct 30 06:51 ET

Will Weakness in Bloomage BioTechnology Corporation Limited's (SHSE:688363) Stock Prove Temporary Given Strong Fundamentals?

Simply Wall StOct 15 19:33 ET

Bloomage BioTechnology Corporation Limited (SHSE:688363) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Simply Wall StSep 12 18:30 ET